OXT and schizophrenia: Other studies that examined the therapeutic role of oxytocin in the neurocognition of patients with schizophrenia failed to yield a significant result, including studies that measured the letter number sequence [155], Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery composite score [125,128], and Repeatable Battery for the Assessment of Neuropsychological Status [17].